Related Experiment Videos
Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells
K Kirtikara1, S G Morham, R Raghow
1Department of Medicine, The University of Tennessee, Memphis, Tennessee 38163, USA.
The Journal of Experimental Medicine
|March 28, 1998
Summary
Cells lacking cyclooxygenase-1 (COX-1) or cyclooxygenase-2 (COX-2) can upregulate the remaining COX gene and related enzymes to maintain prostaglandin E2 (PGE2) production, demonstrating cellular compensation mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Prostaglandin E2 (PGE2) is a crucial mediator in various physiological and pathological processes.
- Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, are key in PGE2 biosynthesis.
- Understanding cellular compensatory mechanisms in prostaglandin synthesis is vital for therapeutic development.
Purpose of the Study:
- To investigate the compensatory responses in PGE2 production in cells deficient in either COX-1 or COX-2.
- To examine the expression of the remaining functional COX isozyme and associated enzymes like cytosolic phospholipase A2 (cPLA2) under various stimuli.
Main Methods:
- Utilized immortalized, nontransformed cells derived from wild-type, COX-1-deficient, and COX-2-deficient mice.
- Treated cells with inflammatory and growth factors including interleukin-1beta (IL-1β), tumor necrosis factor alpha (TNFα), acidic fibroblast growth factor (aFGF), and phorbol myristate acetate (PMA).
- Assessed the expression levels of COX isozymes and cPLA2.
Main Results:
- COX-1(-/-) and COX-2(-/-) cells showed significantly enhanced expression of the remaining functional COX gene compared to wild-type cells.
- Both basal and IL-1β-induced expression of cPLA2 were more pronounced in COX-1(-/-) and COX-2(-/-) cells.
- These findings indicate a coordinated upregulation of alternate COX isozymes and cPLA2 to compensate for genetic defects.
Conclusions:
- Cells possess robust mechanisms to compensate for defects in prostaglandin biosynthesis machinery by upregulating alternative pathways.
- The observed cellular plasticity in gene expression has significant implications for understanding diseases involving COX pathways and for the development of COX inhibitor-based therapies.